Source comparison
CJC-1295 Popular In: Research Application Comparison
Body Composition Studies Preserves pulsatile GH secretion; weekly dosing MK-677 (ibutamoren) Continuous ghrelin activation; cortisol elevation; glucose dysregulation in some models CJC-1295 replicates physiological GH pulses without metabolic side effects Long
This comparison does not assign a generated winner or score.
- Body Composition Studies
- Preserves pulsatile GH secretion; weekly dosing
- MK-677 (ibutamoren)
- Continuous ghrelin activation; cortisol elevation; glucose dysregulation in some models
- CJC-1295 replicates physiological GH pulses without metabolic side effects
- Longevity & Aging Research
- Sustained IGF-1 elevation for 9–11 days; minimal daily administration
- Sermorelin
- Half-life <10 minutes; requires 3–4 daily injections; poor compliance in long-term trials
- Weekly dosing improves protocol adherence across multi-month studies
- Muscle Recovery Protocols
- Amplifies endogenous GHRH; synergistic with GHRP-2 or GHRP-6
- Ipamorelin
- Short half-life; multiple daily doses required; limited pulse amplitude
- CJC-1295 + GHRP combination produces stronger GH pulses with fewer injections
- Metabolic Syndrome Models
- Improves insulin sensitivity; drives lipolysis through pulsatile GH
- Tesamorelin
- Approved for lipodystrophy but expensive; similar mechanism but higher cost per dose
- CJC-1295 offers comparable metabolic benefits at 60% lower material cost
- Sleep & Cognitive Function
- Maintains natural GH secretion peaks during sleep cycles
- Hexarelin
- Desensitization after 4–6 weeks; cortisol/prolactin elevation
- CJC-1295 sustains GH pulse amplitude without receptor downregulation over 12+ weeks